{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:17:46Z","timestamp":1793038666298,"version":"4.5.0"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T00:00:00Z","timestamp":1320278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurosci"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/nrn3114","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T01:03:40Z","timestamp":1320282220000},"page":"723-738","source":"Crossref","is-referenced-by-count":2789,"title":["Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders"],"prefix":"10.1038","volume":"12","author":[{"given":"Berislav V.","family":"Zlokovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,3]]},"reference":[{"key":"BFnrn3114_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic, B. V. The blood\u2013brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178\u2013201 (2008).","journal-title":"Neuron"},{"key":"BFnrn3114_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","volume":"67","author":"MA Moskowitz","year":"2010","unstructured":"Moskowitz, M. A., Lo, E. H. & Iadecola, C. The science of stroke: mechanisms in search of treatments. Neuron 67, 181\u2013198 (2010). A comprehensive review describing mechanisms of ischaemic injury to the neurovascular unit.","journal-title":"Neuron"},{"key":"BFnrn3114_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic, B. V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 28, 202\u2013208 (2005).","journal-title":"Trends Neurosci."},{"key":"BFnrn3114_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1365-2990.2010.01139.x","volume":"37","author":"WR Brown","year":"2011","unstructured":"Brown, W. R. & Thore, C. R. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol. Appl. Neurobiol. 37, 56\u201374 (2011).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrn3114_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nm1287","volume":"11","author":"Z Wu","year":"2005","unstructured":"Wu, Z. et al. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nature Med. 11, 959\u2013965 (2005). A study demonstrating that low expression of MEOX2 in brain endothelium leads to aberrant angiogenesis and vascular regression in Alzheimer's disease.","journal-title":"Nature Med."},{"key":"BFnrn3114_CR6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.20070304","volume":"204","author":"J Paul","year":"2007","unstructured":"Paul, J., Strickland, S. & Melchor, J. P. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J. Exp. Med. 204, 1999\u20132008 (2007). A study showing BBB breakdown in models of Alzheimer's disease.","journal-title":"J. Exp. Med."},{"key":"BFnrn3114_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","volume":"28","author":"BD Zipser","year":"2007","unstructured":"Zipser, B. D. et al. Microvascular injury and blood\u2013brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 28, 977\u2013986 (2007).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nn2073","volume":"11","author":"Z Zhong","year":"2008","unstructured":"Zhong, Z. et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nature Neurosci. 11, 420\u2013422 (2008). A study demonstrating that BSCB defects precede motor neuron degeneration in mice that develop an ALS-like disease.","journal-title":"Nature Neurosci."},{"key":"BFnrn3114_CR9","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1111\/j.1753-4887.2010.00352.x","volume":"68","author":"RN Kalaria","year":"2010","unstructured":"Kalaria, R. N. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr. Rev. 68, S74\u2013S87 (2010).","journal-title":"Nutr. Rev."},{"key":"BFnrn3114_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JAD-2010-091555","volume":"20","author":"DS Knopman","year":"2010","unstructured":"Knopman, D. S. & Roberts, R. Vascular risk factors: imaging and neuropathologic correlates. J. Alzheimers Dis. 20, 699\u2013709 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrn3114_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jnr.22594","volume":"89","author":"K Miyazaki","year":"2011","unstructured":"Miyazaki, K. et al. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J. Neurosci. Res. 89, 718\u2013728 (2011).","journal-title":"J. Neurosci. Res."},{"key":"BFnrn3114_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrn2995","volume":"12","author":"EA Neuwelt","year":"2011","unstructured":"Neuwelt, E. A. et al. Engaging neuroscience to advance translational research in brain barrier biology. Nature Rev. Neurosci. 12, 169\u2013182 (2011).","journal-title":"Nature Rev. Neurosci."},{"key":"BFnrn3114_CR13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1161\/STROKEAHA.108.534388","volume":"40","author":"S Guo","year":"2009","unstructured":"Guo, S. & Lo, E. H. Dysfunctional cell\u2013cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke 40, S4\u2013S7 (2009).","journal-title":"Stroke"},{"key":"BFnrn3114_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic, Z. Molecular biology of the blood\u2013brain and the blood\u2013cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8, 3 (2011).","journal-title":"Fluids Barriers CNS"},{"key":"BFnrn3114_CR15","doi-asserted-by":"publisher","first-page":"31891","DOI":"10.1074\/jbc.274.45.31891","volume":"274","author":"RL O'Kane","year":"1999","unstructured":"O'Kane, R. L., Martinez-Lopez, I., DeJoseph, M. R., Vina, J. R. & Hawkins, R. A. Na+-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood\u2013brain barrier. A mechanism for glutamate removal. J. Biol. Chem. 274, 31891\u201331895 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrn3114_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1042\/BST0371147","volume":"37","author":"GE Hardingham","year":"2009","unstructured":"Hardingham, G. E. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem. Soc. Trans. 37, 1147\u20131160 (2009).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnrn3114_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/1073858410391270","volume":"17","author":"A Elali","year":"2011","unstructured":"Elali, A. & Hermann, D. M. ATP-binding cassette transporters and their roles in protecting the brain. Neuroscientist 17, 423\u2013436 (2011).","journal-title":"Neuroscientist"},{"key":"BFnrn3114_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/me.2010-0095","volume":"25","author":"WE Visser","year":"2011","unstructured":"Visser, W. E., Friesema, E. C. & Visser, T. J. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol. Endocrinol. 25, 1\u201314 (2011).","journal-title":"Mol. Endocrinol."},{"key":"BFnrn3114_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0006-8993(85)90423-8","volume":"336","author":"BV Zlokovic","year":"1985","unstructured":"Zlokovic, B. V., Begley, D. J. & Chain-Eliash, D. G. Blood\u2013brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine). Brain Res. 336, 125\u2013132 (1985).","journal-title":"Brain Res."},{"key":"BFnrn3114_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1471-4159.1987.tb03431.x","volume":"49","author":"BV Zlokovic","year":"1987","unstructured":"Zlokovic, B. V., Lipovac, M. N., Begley, D. J., Davson, H. & Rakic, L. Transport of leucine-enkephalin across the blood\u2013brain barrier in the perfused guinea pig brain. J. Neurochem. 49, 310\u2013315 (1987).","journal-title":"J. Neurochem."},{"key":"BFnrn3114_CR21","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1471-4159.1989.tb08522.x","volume":"53","author":"BV Zlokovic","year":"1989","unstructured":"Zlokovic, B. V., Mackic, J. B., Djuricic, B. & Davson, H. Kinetic analysis of leucine\u2013enkephalin cellular uptake at the luminal side of the blood\u2013brain barrier of an in situ perfused guinea-pig brain. J. Neurochem. 53, 1333\u20131340 (1989).","journal-title":"J. Neurochem."},{"key":"BFnrn3114_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0005-2736(90)90097-8","volume":"1025","author":"BV Zlokovic","year":"1990","unstructured":"Zlokovic, B. V. et al. Kinetics of arginine-vasopressin uptake at the blood\u2013brain barrier. Biochim. Biophys. Acta 1025, 191\u2013198 (1990).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrn3114_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0006-8993(85)90963-1","volume":"358","author":"BV Zlokovic","year":"1985","unstructured":"Zlokovic, B. V., Segal, M. B., Begley, D. J., Davson, H. & Rakic, L. Permeability of the blood\u2013cerebrospinal fluid and blood\u2013brain barriers to thyrotropin-releasing hormone. Brain Res. 358, 191\u2013199 (1985).","journal-title":"Brain Res."},{"key":"BFnrn3114_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/jcbfm.2008.131","volume":"29","author":"D Dogrukol-Ak","year":"2009","unstructured":"Dogrukol-Ak, D. et al. Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models. J. Cereb. Blood Flow Metab. 29, 411\u2013422 (2009).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnrn3114_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","volume":"12","author":"WM Pardridge","year":"2007","unstructured":"Pardridge, W. M. Blood\u2013brain barrier delivery. Drug Discov. Today 12, 54\u201361 (2007).","journal-title":"Drug Discov. Today"},{"key":"BFnrn3114_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.neuron.2010.08.007","volume":"67","author":"T Nishijima","year":"2010","unstructured":"Nishijima, T. et al. Neuronal activity drives localized blood\u2013brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 67, 834\u2013846 (2010).","journal-title":"Neuron"},{"key":"BFnrn3114_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000264398","volume":"63","author":"WA Banks","year":"2010","unstructured":"Banks, W. A. Blood\u2013brain barrier as a regulatory interface. Forum Nutr. 63, 102\u2013110 (2010).","journal-title":"Forum Nutr."},{"key":"BFnrn3114_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/jcbfm.2008.117","volume":"29","author":"R Deane","year":"2009","unstructured":"Deane, R. et al. Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood\u2013brain barrier. J. Cereb. Blood Flow Metab. 29, 25\u201333 (2009).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnrn3114_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuron.2007.03.013","volume":"54","author":"C Iadecola","year":"2007","unstructured":"Iadecola, C. Astrocytes take center stage in salt sensing. Neuron 54, 3\u20135 (2007).","journal-title":"Neuron"},{"key":"BFnrn3114_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuron.2007.03.014","volume":"54","author":"H Shimizu","year":"2007","unstructured":"Shimizu, H. et al. Glial Nax channels control lactate signaling to neurons for brain [Na+] sensing. Neuron 54, 59\u201372 (2007).","journal-title":"Neuron"},{"key":"BFnrn3114_CR31","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1212\/WNL.0b013e3181a41228","volume":"72","author":"JS Henkel","year":"2009","unstructured":"Henkel, J. S., Beers, D. R., Wen, S., Bowser, R. & Appel, S. H. Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology 72, 1614\u20131616 (2009).","journal-title":"Neurology"},{"key":"BFnrn3114_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2010.06.017","volume":"1812","author":"JI Alvarez","year":"2011","unstructured":"Alvarez, J. I., Cayrol, R. & Prat, A. Disruption of central nervous system barriers in multiple sclerosis. Biochim. Biophys. Acta 1812, 252\u2013264 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrn3114_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","volume":"68","author":"RD Bell","year":"2010","unstructured":"Bell, R. D. et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409\u2013427 (2010). A study showing that loss of pericytes leads to BBB breakdown and hypoperfusion, resulting in secondary neurodegenerative changes.","journal-title":"Neuron"},{"key":"BFnrn3114_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","volume":"8","author":"GA Rosenberg","year":"2009","unstructured":"Rosenberg, G. A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 8, 205\u2013216 (2009).","journal-title":"Lancet Neurol."},{"key":"BFnrn3114_CR35","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/nm1498","volume":"12","author":"T Cheng","year":"2006","unstructured":"Cheng, T. et al. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nature Med. 12, 1278\u20131285 (2006).","journal-title":"Nature Med."},{"key":"BFnrn3114_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for blood\u2013brain barrier integrity during embryogenesis. Nature 468, 562\u2013566 (2010). A study showing that pericytes control the formation of the BBB during embryonic development.","journal-title":"Nature"},{"key":"BFnrn3114_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.devcel.2011.01.011","volume":"20","author":"F Li","year":"2011","unstructured":"Li, F. et al. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev. Cell 20, 291\u2013302 (2011). A study showing that N-cadherin mediates pericyte\u2013endothelial attachment in the cerebral blood vessels, preventing microhaemorrhages.","journal-title":"Dev. Cell"},{"key":"BFnrn3114_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik, A. et al. Pericytes regulate the blood\u2013brain barrier. Nature 468, 557\u2013561 (2010). A study that reveals a role for pericytes in the maintenance of the BBB in vivo during adulthood.","journal-title":"Nature"},{"key":"BFnrn3114_CR39","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.78.12.7820","volume":"78","author":"RD Broadwell","year":"1981","unstructured":"Broadwell, R. D. & Salcman, M. Expanding the definition of the blood\u2013brain barrier to protein. Proc. Natl Acad. Sci. USA 78, 7820\u20137824 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn3114_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.neurobiolaging.2003.07.007","volume":"25","author":"M Mhatre","year":"2004","unstructured":"Mhatre, M. et al. Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol. Aging 25, 783\u2013793 (2004).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR41","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1161\/STROKEAHA.110.584920","volume":"41","author":"B Chen","year":"2010","unstructured":"Chen, B., Cheng, Q., Yang, K. & Lyden, P. D. Thrombin mediates severe neurovascular injury during ischemia. Stroke 41, 2348\u20132352 (2010).","journal-title":"Stroke"},{"key":"BFnrn3114_CR42","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0092-8674(00)80483-3","volume":"91","author":"ZL Chen","year":"1997","unstructured":"Chen, Z. L. & Strickland, S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917\u2013925 (1997).","journal-title":"Cell"},{"key":"BFnrn3114_CR43","first-page":"3437","volume":"119","author":"Z Zhong","year":"2009","unstructured":"Zhong, Z. et al. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J. Clin. Invest. 119, 3437\u20133449 (2009). A study showing that APC prevents BSCB breakdown, suppresses activation of microglia and protects motor neurons in ALS mice.","journal-title":"J. Clin. Invest."},{"key":"BFnrn3114_CR44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1474-4422(07)70055-8","volume":"6","author":"JM Simard","year":"2007","unstructured":"Simard, J. M., Kent, T. A., Chen, M., Tarasov, K. V. & Gerzanich, V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 6, 258\u2013268 (2007).","journal-title":"Lancet Neurol."},{"key":"BFnrn3114_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.expneurol.2010.09.016","volume":"227","author":"A Hoshi","year":"2011","unstructured":"Hoshi, A., Yamamoto, T., Shimizu, K., Sugiura, Y. & Ugawa, Y. Chemical preconditioning-induced reactive astrocytosis contributes to the reduction of post-ischemic edema through aquaporin-4 downregulation. Exp. Neurol. 227, 89\u201395 (2011).","journal-title":"Exp. Neurol."},{"key":"BFnrn3114_CR46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola, C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nature Rev. Neurosci. 5, 347\u2013360 (2004).","journal-title":"Nature Rev. Neurosci."},{"key":"BFnrn3114_CR47","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature05193","volume":"443","author":"CM Peppiatt","year":"2006","unstructured":"Peppiatt, C. M., Howarth, C., Mobbs, P. & Attwell, D. Bidirectional control of CNS capillary diameter by pericytes. Nature 443, 700\u2013704 (2006). A study showing that pericytes control the diameter of brain capillaries in response to signals from neurons.","journal-title":"Nature"},{"key":"BFnrn3114_CR48","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/nm.2022","volume":"15","author":"M Yemisci","year":"2009","unstructured":"Yemisci, M. et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nature Med. 15, 1031\u20131037 (2009).","journal-title":"Nature Med."},{"key":"BFnrn3114_CR49","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1169096","volume":"323","author":"KV Kuchibhotla","year":"2009","unstructured":"Kuchibhotla, K. V., Lattarulo, C. R., Hyman, B. T. & Bacskai, B. J. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323, 1211\u20131215 (2009).","journal-title":"Science"},{"key":"BFnrn3114_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1196\/annals.1379.004","volume":"1097","author":"T Takano","year":"2007","unstructured":"Takano, T., Han, X., Deane, R., Zlokovic, B. & Nedergaard, M. Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease. Ann. NY Acad. Sci. 1097, 40\u201350 (2007).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrn3114_CR51","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1212\/WNL.53.7.1391","volume":"53","author":"CD Smith","year":"1999","unstructured":"Smith, C. D. et al. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology 53, 1391\u20131396 (1999).","journal-title":"Neurology"},{"key":"BFnrn3114_CR52","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM200008173430701","volume":"343","author":"SY Bookheimer","year":"2000","unstructured":"Bookheimer, S. Y. et al. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343, 450\u2013456 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrn3114_CR53","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ana.20493","volume":"57","author":"A Ruitenberg","year":"2005","unstructured":"Ruitenberg, A. et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann. Neurol. 57, 789\u2013794 (2005).","journal-title":"Ann. Neurol."},{"key":"BFnrn3114_CR54","doi-asserted-by":"publisher","first-page":"17035","DOI":"10.1523\/JNEUROSCI.3987-10.2010","volume":"30","author":"YI Sheline","year":"2010","unstructured":"Sheline, Y. I. et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF A\u03b242. J. Neurosci. 30, 17035\u201317040 (2010).","journal-title":"J. Neurosci."},{"key":"BFnrn3114_CR55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3233\/JAD-2010-100216","volume":"21","author":"X Wang","year":"2010","unstructured":"Wang, X. et al. Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-\u03b2 oligomerization in rats. J. Alzheimers Dis. 21, 813\u2013822 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrn3114_CR56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D. M. et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535\u2013539 (2002). A study showing that amyloid-\u03b2 oligomers inhibit neuronal activity in the hipocampus.","journal-title":"Nature"},{"key":"BFnrn3114_CR57","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2353\/ajpath.2010.090750","volume":"177","author":"MA Koike","year":"2010","unstructured":"Koike, M. A., Green, K. N., Blurton-Jones, M. & Laferla, F. M. Oligemic hypoperfusion differentially affects tau and amyloid-\u03b2. Am. J. Pathol. 177, 300\u2013310 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrn3114_CR58","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11064-006-9199-3","volume":"32","author":"W Gordon-Krajcer","year":"2007","unstructured":"Gordon-Krajcer, W., Kozniewska, E., Lazarewicz, J. W. & Ksiezak-Reding, H. Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils. Neurochem. Res. 32, 729\u2013737 (2007).","journal-title":"Neurochem. Res."},{"key":"BFnrn3114_CR59","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.2353\/ajpath.2010.100339","volume":"177","author":"B Ongali","year":"2010","unstructured":"Ongali, B. et al. Transgenic mice overexpressing APP and transforming growth factor-\u03b21 feature cognitive and vascular hallmarks of Alzheimer's disease. Am. J. Pathol. 177, 3071\u20133080 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrn3114_CR60","doi-asserted-by":"publisher","first-page":"18727","DOI":"10.1073\/pnas.0606298103","volume":"103","author":"X Sun","year":"2006","unstructured":"Sun, X. et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl Acad. Sci. USA 103, 18727\u201318732 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn3114_CR61","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.1074\/jbc.M608856200","volume":"282","author":"X Zhang","year":"2007","unstructured":"Zhang, X. et al. Hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1)-mediated hypoxia increases BACE1 expression and \u03b2-amyloid generation. J. Biol. Chem. 282, 10873\u201310880 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrn3114_CR62","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1471-4159.2008.05858.x","volume":"108","author":"M Guglielmotto","year":"2009","unstructured":"Guglielmotto, M. et al. The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1\u03b1. J. Neurochem. 108, 1045\u20131056 (2009).","journal-title":"J. Neurochem."},{"key":"BFnrn3114_CR63","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.neurobiolaging.2007.10.011","volume":"30","author":"L Li","year":"2009","unstructured":"Li, L. et al. Hypoxia increases A\u03b2 generation by altering \u03b2- and \u03b3-cleavage of APP. Neurobiol. Aging 30, 1091\u20131098 (2009).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR64","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neulet.2010.03.037","volume":"474","author":"H Fang","year":"2010","unstructured":"Fang, H., Zhang, L. F., Meng, F. T., Du, X. & Zhou, J. N. Acute hypoxia promote the phosphorylation of tau via ERK pathway. Neurosci. Lett. 474, 173\u2013177 (2010).","journal-title":"Neurosci. Lett."},{"key":"BFnrn3114_CR65","doi-asserted-by":"publisher","first-page":"e19229","DOI":"10.1371\/journal.pone.0019229","volume":"6","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS ONE 6, e19229 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrn3114_CR66","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ncb1819","volume":"11","author":"RD Bell","year":"2009","unstructured":"Bell, R. D. et al. SRF and myocardin regulate LRP-mediated amyloid-\u03b2 clearance in brain vascular cells. Nature Cell Biol. 11, 143\u2013153 (2009). A study showing that hypoxia leads to a failure of LRP1-mediated amyloid-\u03b2 clearance from brain arteries through an elevation in the levels of myocardin and serum response factor.","journal-title":"Nature Cell Biol."},{"key":"BFnrn3114_CR67","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s11064-007-9540-5","volume":"33","author":"C Munch","year":"2008","unstructured":"Munch, C. et al. Chemical hypoxia facilitates alternative splicing of EAAT2 in presymptomatic APP23 transgenic mice. Neurochem. Res. 33, 1005\u20131010 (2008).","journal-title":"Neurochem. Res."},{"key":"BFnrn3114_CR68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbrc.2007.09.102","volume":"364","author":"HE Boycott","year":"2007","unstructured":"Boycott, H. E., Dallas, M., Boyle, J. P., Pearson, H. A. & Peers, C. Hypoxia suppresses astrocyte glutamate transport independently of amyloid formation. Biochem. Biophys. Res. Commun. 364, 100\u2013104 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrn3114_CR69","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10863-009-9247-1","volume":"41","author":"C Carvalho","year":"2009","unstructured":"Carvalho, C. et al. Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia. J. Bioenerg. Biomembr. 41, 433\u2013440 (2009).","journal-title":"J. Bioenerg. Biomembr."},{"key":"BFnrn3114_CR70","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2174\/187152710791556113","volume":"9","author":"JC Fernandez-Checa","year":"2010","unstructured":"Fernandez-Checa, J. C. et al. Oxidative stress and altered mitochondrial function in neurodegenerative diseases: lessons from mouse models. CNS Neurol. Disord. Drug Targets 9, 439\u2013454 (2010).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"BFnrn3114_CR71","doi-asserted-by":"publisher","first-page":"S475","DOI":"10.3233\/JAD-2010-100669","volume":"20","author":"SC Correia","year":"2010","unstructured":"Correia, S. C. et al. Mitochondria: the missing link between preconditioning and neuroprotection. J. Alzheimers Dis. 20, S475\u2013S485 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrn3114_CR72","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C. & Gage, F. H. Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918\u2013934 (2010).","journal-title":"Cell"},{"key":"BFnrn3114_CR73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-2094-8-26","volume":"8","author":"P Grammas","year":"2011","unstructured":"Grammas, P. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J. Neuroinflammation 8, 26 (2011).","journal-title":"J. Neuroinflammation"},{"key":"BFnrn3114_CR74","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9440(10)65280-7","volume":"154","author":"P Grammas","year":"1999","unstructured":"Grammas, P., Moore, P. & Weigel, P. H. Microvessels from Alzheimer's disease brains kill neurons in vitro. Am. J. Pathol. 154, 337\u2013342 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrn3114_CR75","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.exger.2006.03.018","volume":"41","author":"KV Moser","year":"2006","unstructured":"Moser, K. V., Stockl, P. & Humpel, C. Cholinergic neurons degenerate when exposed to conditioned medium of primary rat brain capillary endothelial cells: counteraction by NGF, MK-801 and inflammation. Exp. Gerontol. 41, 609\u2013618 (2006).","journal-title":"Exp. Gerontol."},{"key":"BFnrn3114_CR76","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.2353\/ajpath.2010.090406","volume":"176","author":"X Yin","year":"2010","unstructured":"Yin, X., Wright, J., Wall, T. & Grammas, P. Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am. J. Pathol. 176, 1600\u20131606 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrn3114_CR77","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/jcbfm.1991.121","volume":"11","author":"AJ Martin","year":"1991","unstructured":"Martin, A. J., Friston, K. J., Colebatch, J. G. & Frackowiak, R. S. Decreases in regional cerebral blood flow with normal aging. J. Cereb. Blood Flow Metab. 11, 684\u2013689 (1991).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnrn3114_CR78","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1152\/jn.00270.2010","volume":"104","author":"B Li","year":"2010","unstructured":"Li, B. & Freeman, R. D. Neurometabolic coupling in the lateral geniculate nucleus changes with extended age. J. Neurophysiol. 104, 414\u2013425 (2010).","journal-title":"J. Neurophysiol."},{"key":"BFnrn3114_CR79","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram, L., McQueen, M. B., Mullin, K., Blacker, D. & Tanzi, R. E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genet. 39, 17\u201323 (2007).","journal-title":"Nature Genet."},{"key":"BFnrn3114_CR80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim, J., Basak, J. M. & Holtzman, D. M. The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287\u2013303 (2009).","journal-title":"Neuron"},{"key":"BFnrn3114_CR81","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese, P. B., Castellano, J. M. & Holtzman, D. M. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 10, 241\u2013252 (2011).","journal-title":"Lancet Neurol."},{"key":"BFnrn3114_CR82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneurol.2009.913","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty, M., Beason-Held, L., An, Y., Kraut, M. A. & Resnick, S. M. APOE \u025b4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch. Neurol. 67, 93\u201398 (2010).","journal-title":"Arch. Neurol."},{"key":"BFnrn3114_CR83","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","volume":"30","author":"AJ Farrall","year":"2009","unstructured":"Farrall, A. J. & Wardlaw, J. M. Blood\u2013brain barrier: ageing and microvascular disease \u2014 systematic review and meta-analysis. Neurobiol. Aging 30, 337\u2013352 (2009).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR84","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/jnnp.2009.172072","volume":"81","author":"R Topakian","year":"2010","unstructured":"Topakian, R., Barrick, T. R., Howe, F. A. & Markus, H. S. Blood\u2013brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J. Neurol. Neurosurg. Psychiatry 81, 192\u2013197 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrn3114_CR85","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.exger.2008.12.004","volume":"44","author":"RL Chen","year":"2009","unstructured":"Chen, R. L. et al. Age-related changes in choroid plexus and blood\u2013cerebrospinal fluid barrier function in the sheep. Exp. Gerontol. 44, 289\u2013296 (2009).","journal-title":"Exp. Gerontol."},{"key":"BFnrn3114_CR86","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","volume":"64","author":"E Farkas","year":"2001","unstructured":"Farkas, E. & Luiten, P. G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64, 575\u2013611 (2001).","journal-title":"Prog. Neurobiol."},{"key":"BFnrn3114_CR87","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","volume":"360","author":"GM Savva","year":"2009","unstructured":"Savva, G. M. et al. Age, neuropathology, and dementia. N. Engl. J. Med. 360, 2302\u20132309 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrn3114_CR88","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000285518","volume":"7","author":"KA Jellinger","year":"2010","unstructured":"Jellinger, K. A. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Neurodegener. Dis. 7, 112\u2013115 (2010).","journal-title":"Neurodegener. Dis."},{"key":"BFnrn3114_CR89","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/WCO.0b013e328341f8c0","volume":"24","author":"C Cordonnier","year":"2011","unstructured":"Cordonnier, C. Brain microbleeds: more evidence, but still a clinical dilemma. Curr. Opin. Neurol. 24, 69\u201374 (2011).","journal-title":"Curr. Opin. Neurol."},{"issue":"6","key":"BFnrn3114_CR90","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.22516","volume":"70","author":"Anand Viswanathan","year":"2011","unstructured":"Viswanathan, A. & Greenberg, S. M. Cerebral amyloid angiopathy (CAA) in the elderly. Ann. Neurol. 10 Jun 2011 (doi:10.1002\/ana.22516).","journal-title":"Annals of Neurology"},{"key":"BFnrn3114_CR91","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1096\/fj.09-139584","volume":"24","author":"S Fossati","year":"2010","unstructured":"Fossati, S. et al. Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-\u03b2 variants in cells composing the cerebral vessel walls. FASEB J. 24, 229\u2013241 (2010).","journal-title":"FASEB J."},{"key":"BFnrn3114_CR92","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux, A. et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nature Genet. 38, 24\u201326 (2006).","journal-title":"Nature Genet."},{"key":"BFnrn3114_CR93","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/archneur.1990.00530110068019","volume":"47","author":"JI Engelhardt","year":"1990","unstructured":"Engelhardt, J. I. & Appel, S. H. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol. 47, 1210\u20131216 (1990).","journal-title":"Arch. Neurol."},{"key":"BFnrn3114_CR94","doi-asserted-by":"publisher","first-page":"e1205","DOI":"10.1371\/journal.pone.0001205","volume":"2","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis, S. et al. Evidence of compromised blood\u2013spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE 2, e1205 (2007).","journal-title":"PLoS ONE"},{"key":"BFnrn3114_CR95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","volume":"1398","author":"S Garbuzova-Davis","year":"2011","unstructured":"Garbuzova-Davis, S. et al. Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res. 1398, 113\u2013125 (2011).","journal-title":"Brain Res."},{"key":"BFnrn3114_CR96","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","volume":"26","author":"C Zhao","year":"2007","unstructured":"Zhao, C., Ling, Z., Newman, M. B., Bhatia, A. & Carvey, P. M. TNF-\u03b1 knockout and minocycline treatment attenuates blood\u2013brain barrier leakage in MPTP-treated mice. Neurobiol. Dis. 26, 36\u201346 (2007).","journal-title":"Neurobiol. Dis."},{"key":"BFnrn3114_CR97","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","volume":"107","author":"X Chen","year":"2008","unstructured":"Chen, X., Lan, X., Roche, I., Liu, R. & Geiger, J. D. Caffeine protects against MPTP-induced blood\u2013brain barrier dysfunction in mouse striatum. J. Neurochem. 107, 1147\u20131157 (2008).","journal-title":"J. Neurochem."},{"key":"BFnrn3114_CR98","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","volume":"216","author":"YX Chao","year":"2009","unstructured":"Chao, Y. X., He, B. P. & Tay, S. S. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. J. Neuroimmunol. 216, 39\u201350 (2009).","journal-title":"J. Neuroimmunol."},{"key":"BFnrn3114_CR99","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/WCO.0b013e3283050461","volume":"21","author":"A Elbaz","year":"2008","unstructured":"Elbaz, A. & Moisan, F. Update in the epidemiology of Parkinson's disease. Curr. Opin. Neurol. 21, 454\u2013460 (2008).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrn3114_CR100","first-page":"255","volume":"46","author":"E Bertrand","year":"2008","unstructured":"Bertrand, E. et al. Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study. Folia Neuropathol. 46, 255\u2013270 (2008).","journal-title":"Folia Neuropathol."},{"key":"BFnrn3114_CR101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000165343","volume":"61","author":"HT Benamer","year":"2009","unstructured":"Benamer, H. T. & Grosset, D. G. Vascular parkinsonism: a clinical review. Eur. Neurol. 61, 11\u201315 (2009).","journal-title":"Eur. Neurol."},{"key":"BFnrn3114_CR102","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuro.2008.10.007","volume":"30","author":"J Duran-Vilaregut","year":"2009","unstructured":"Duran-Vilaregut, J. et al. Blood\u2013brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid. Neurotoxicology 30, 136\u2013143 (2009).","journal-title":"Neurotoxicology"},{"key":"BFnrn3114_CR103","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0197-4580(97)00111-5","volume":"18","author":"AD Mooradian","year":"1997","unstructured":"Mooradian, A. D., Chung, H. C. & Shah, G. N. GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol. Aging 18, 469\u2013474 (1997).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR104","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pscychresns.2006.12.003","volume":"155","author":"A Hunt","year":"2007","unstructured":"Hunt, A. et al. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psychiatry Res. 155, 147\u2013154 (2007).","journal-title":"Psychiatry Res."},{"key":"BFnrn3114_CR105","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1586\/ern.10.136","volume":"10","author":"K Herholz","year":"2010","unstructured":"Herholz, K. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Rev. Neurother. 10, 1667\u20131673 (2010).","journal-title":"Expert Rev. Neurother."},{"key":"BFnrn3114_CR106","first-page":"1778","volume":"47","author":"L Mosconi","year":"2006","unstructured":"Mosconi, L. et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J. Nucl. Med. 47, 1778\u20131786 (2006).","journal-title":"J. Nucl. Med."},{"key":"BFnrn3114_CR107","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00259-007-0454-x","volume":"34","author":"M Samuraki","year":"2007","unstructured":"Samuraki, M. et al. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 34, 1658\u20131669 (2007).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"BFnrn3114_CR108","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","volume":"29","author":"L Mosconi","year":"2008","unstructured":"Mosconi, L. et al. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol. Aging 29, 676\u2013692 (2008).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR109","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/380168a0","volume":"380","author":"T Thomas","year":"1996","unstructured":"Thomas, T., Thomas, G., McLendon, C., Sutton, T. & Mullan, M. \u03b2-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168\u2013171 (1996). A study showing that amyloid-\u03b2 constricts blood vessels.","journal-title":"Nature"},{"key":"BFnrn3114_CR110","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5715","volume":"2","author":"C Iadecola","year":"1999","unstructured":"Iadecola, C. et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nature Neurosci. 2, 157\u2013161 (1999). A study showing that dysregulation in CBF occurs before amyloid-\u03b2 deposition in a mouse model of Alzheimer's disease.","journal-title":"Nature Neurosci."},{"key":"BFnrn3114_CR111","doi-asserted-by":"publisher","first-page":"9735","DOI":"10.1073\/pnas.97.17.9735","volume":"97","author":"K Niwa","year":"2000","unstructured":"Niwa, K. et al. A\u03b21\u201340-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc. Natl Acad. Sci. USA 97, 9735\u20139740 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn3114_CR112","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1073\/pnas.1015413108","volume":"108","author":"L Park","year":"2011","unstructured":"Park, L. et al. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-\u03b2. Proc. Natl Acad. Sci. USA 108, 5063\u20135068 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn3114_CR113","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1073\/pnas.0608251104","volume":"104","author":"N Chow","year":"2007","unstructured":"Chow, N. et al. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc. Natl Acad. Sci. USA 104, 823\u2013828 (2007). A study showing that elevated levels of myocardin and serum response factor lead to a hypercontractile phenotype of brain arteries in Alzheimer's disease.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn3114_CR114","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","volume":"30","author":"AL Bartels","year":"2009","unstructured":"Bartels, A. L. et al. Blood\u2013brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol. Aging 30, 1818\u20131824 (2009).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR115","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","volume":"115","author":"AL Bartels","year":"2008","unstructured":"Bartels, A. L. et al. Decreased blood\u2013brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. J. Neural Transm. 115, 1001\u20131009 (2008).","journal-title":"J. Neural Transm."},{"key":"BFnrn3114_CR116","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1212\/WNL.0b013e3181d3e2dd","volume":"74","author":"RR Rule","year":"2010","unstructured":"Rule, R. R., Schuff, N., Miller, R. G. & Weiner, M. W. Gray matter perfusion correlates with disease severity in ALS. Neurology 74, 821\u2013827 (2010).","journal-title":"Neurology"},{"key":"BFnrn3114_CR117","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/122.9.1667","volume":"122","author":"GJ Harris","year":"1999","unstructured":"Harris, G. J. et al. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain 122, 1667\u20131678 (1999).","journal-title":"Brain"},{"key":"BFnrn3114_CR118","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0006-8993(00)02506-3","volume":"872","author":"AW Deckel","year":"2000","unstructured":"Deckel, A. W. & Duffy, J. D. Vasomotor hyporeactivity in the anterior cerebral artery during motor activation in Huntington's disease patients. Brain Res. 872, 258\u2013261 (2000).","journal-title":"Brain Res."},{"key":"BFnrn3114_CR119","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nature04481","volume":"438","author":"DA Greenberg","year":"2005","unstructured":"Greenberg, D. A. & Jin, K. From angiogenesis to neuropathology. Nature 438, 954\u2013959 (2005).","journal-title":"Nature"},{"key":"BFnrn3114_CR120","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1152\/physrev.00031.2008","volume":"89","author":"C Ruiz de Almodovar","year":"2009","unstructured":"Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M. & Carmeliet, P. Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 89, 607\u2013648 (2009).","journal-title":"Physiol. Rev."},{"key":"BFnrn3114_CR121","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrn2336","volume":"9","author":"S Zacchigna","year":"2008","unstructured":"Zacchigna, S., Lambrechts, D. & Carmeliet, P. Neurovascular signalling defects in neurodegeneration. Nature Rev. Neurosci. 9, 169\u2013181 (2008).","journal-title":"Nature Rev. Neurosci."},{"key":"BFnrn3114_CR122","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neuron.2011.01.023","volume":"69","author":"MK Lehtinen","year":"2011","unstructured":"Lehtinen, M. K. et al. The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron 69, 893\u2013905 (2011).","journal-title":"Neuron"},{"key":"BFnrn3114_CR123","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2004.05.017","volume":"366","author":"D Paris","year":"2004","unstructured":"Paris, D. et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci. Lett. 366, 80\u201385 (2004).","journal-title":"Neurosci. Lett."},{"key":"BFnrn3114_CR124","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","volume":"8","author":"H Chabriat","year":"2009","unstructured":"Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E. & Bousser, M. G. Cadasil. Lancet Neurol. 8, 643\u2013653 (2009).","journal-title":"Lancet Neurol."},{"key":"BFnrn3114_CR125","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/ana.22088","volume":"68","author":"M Rotstein","year":"2010","unstructured":"Rotstein, M. et al. Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann. Neurol. 68, 955\u2013958 (2010).","journal-title":"Ann. Neurol."},{"key":"BFnrn3114_CR126","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/hmg\/ddl032","volume":"15","author":"D Wang","year":"2006","unstructured":"Wang, D. et al. A mouse model for Glut-1 haploinsufficiency. Hum. Mol. Genet. 15, 1169\u20131179 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrn3114_CR127","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","volume":"330","author":"YS Eisele","year":"2010","unstructured":"Eisele, Y. S. et al. Peripherally applied A\u03b2-containing inoculates induce cerebral \u03b2-amyloidosis. Science 330, 980\u2013982 (2010). A study showing that peripheral amyloid-\u03b2 contributes to the development of cerebral \u03b2-amyloidosis in a mouse model of Alzheimer's disease.","journal-title":"Science"},{"key":"BFnrn3114_CR128","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jnr.22603","volume":"89","author":"JG Sutcliffe","year":"2011","unstructured":"Sutcliffe, J. G., Hedlund, P. B., Thomas, E. A., Bloom, F. E. & Hilbush, B. S. Peripheral reduction of \u03b2-amyloid is sufficient to reduce brain \u03b2-amyloid: implications for Alzheimer's disease. J. Neurosci. Res. 89, 808\u2013814 (2011).","journal-title":"J. Neurosci. Res."},{"key":"BFnrn3114_CR129","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/jnr.22670","volume":"89","author":"AP Sagare","year":"2011","unstructured":"Sagare, A. P., Winkler, E. A., Bell, R. D., Deane, R. & Zlokovic, B. V. From the liver to the blood\u2013brain barrier: an interconnected system regulating brain amyloid-\u03b2 levels. J. Neurosci. Res. 89, 967\u2013968 (2011).","journal-title":"J. Neurosci. Res."},{"key":"BFnrn3114_CR130","first-page":"463","volume":"10","author":"M Ujiie","year":"2003","unstructured":"Ujiie, M., Dickstein, D. L., Carlow, D. A. & Jefferies, W. A. Blood\u2013brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10, 463\u2013470 (2003).","journal-title":"Microcirculation"},{"key":"BFnrn3114_CR131","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","volume":"38","author":"JB Mackic","year":"2002","unstructured":"Mackic, J. B. et al. Circulating amyloid-\u03b2 peptide crosses the blood\u2013brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vascul. Pharmacol. 38, 303\u2013313 (2002).","journal-title":"Vascul. Pharmacol."},{"key":"BFnrn3114_CR132","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1046\/j.1471-4159.1998.70010210.x","volume":"70","author":"JB Mackic","year":"1998","unstructured":"Mackic, J. B. et al. Cerebrovascular accumulation and increased blood\u2013brain barrier permeability to circulating Alzheimer's amyloid \u03b2 peptide in aged squirrel monkey with cerebral amyloid angiopathy. J. Neurochem. 70, 210\u2013215 (1998).","journal-title":"J. Neurochem."},{"key":"BFnrn3114_CR133","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/nbdi.1997.0132","volume":"4","author":"JF Poduslo","year":"1997","unstructured":"Poduslo, J. F., Curran, G. L., Haggard, J. J., Biere, A. L. & Selkoe, D. J. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid \u03b2-protein 1\u201340 at the blood\u2013brain barrier. Neurobiol. Dis. 4, 27\u201334 (1997).","journal-title":"Neurobiol. Dis."},{"key":"BFnrn3114_CR134","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1097\/00001756-199611040-00040","volume":"7","author":"JR Ghilardi","year":"1996","unstructured":"Ghilardi, J. R. et al. Intra-arterial infusion of 125IA\u03b2 1\u201340 labels amyloid deposits in the aged primate brain in vivo. Neuroreport 7, 2607\u20132611 (1996).","journal-title":"Neuroreport"},{"key":"BFnrn3114_CR135","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1006\/bbrc.1993.2582","volume":"197","author":"BV Zlokovic","year":"1993","unstructured":"Zlokovic, B. V. et al. Blood\u2013brain barrier transport of circulating Alzheimer's amyloid \u03b2. Biochem. Biophys. Res. Commun. 197, 1034\u20131040 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrn3114_CR136","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0304-3940(96)12462-9","volume":"206","author":"CL Martel","year":"1996","unstructured":"Martel, C. L., Mackic, J. B., McComb, J. G., Ghiso, J. & Zlokovic, B. V. Blood\u2013brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid \u03b2 in guinea pigs. Neurosci. Lett. 206, 157\u2013160 (1996).","journal-title":"Neurosci. Lett."},{"key":"BFnrn3114_CR137","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1635","volume":"13","author":"A Sagare","year":"2007","unstructured":"Sagare, A. et al. Clearance of amyloid-\u03b2 by circulating lipoprotein receptors. Nature Med. 13, 1029\u20131031 (2007). A study showing that soluble LRP1 binds amyloid-\u03b2 in the cirulation, preventing re-entry of this peptide into the brain.","journal-title":"Nature Med."},{"key":"BFnrn3114_CR138","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1126\/science.1067568","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M. & Holtzman, D. M. Brain to plasma amyloid-\u03b2 efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264\u20132267 (2002). A study showing that a circulating anti-amyloid-\u03b2 antibody promotes efflux of this peptide from brain to blood.","journal-title":"Science"},{"key":"BFnrn3114_CR139","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0002-9440(10)61715-4","volume":"159","author":"EM Sigurdsson","year":"2001","unstructured":"Sigurdsson, E. M., Scholtzova, H., Mehta, P. D., Frangione, B. & Wisniewski, T. Immunization with a nontoxic\/nonfibrillar amyloid-\u03b2 homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am. J. Pathol. 159, 439\u2013447 (2001).","journal-title":"Am. J. Pathol."},{"key":"BFnrn3114_CR140","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1471-4159.2002.00889.x","volume":"81","author":"RB DeMattos","year":"2002","unstructured":"DeMattos, R. B. et al. Plaque-associated disruption of CSF and plasma amyloid-\u03b2 (A\u03b2) equilibrium in a mouse model of Alzheimer's disease. J. Neurochem. 81, 229\u2013236 (2002).","journal-title":"J. Neurochem."},{"key":"BFnrn3114_CR141","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1523\/JNEUROSCI.23-01-00029.2003","volume":"23","author":"Y Matsuoka","year":"2003","unstructured":"Matsuoka, Y. et al. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to \u03b2-amyloid. J. Neurosci. 23, 29\u201333 (2003).","journal-title":"J. Neurosci."},{"key":"BFnrn3114_CR142","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/mt.2009.115","volume":"17","author":"Y Liu","year":"2009","unstructured":"Liu, Y. et al. Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease. Mol. Ther. 17, 1381\u20131386 (2009).","journal-title":"Mol. Ther."},{"key":"BFnrn3114_CR143","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mcn.2010.05.014","volume":"45","author":"Y Liu","year":"2010","unstructured":"Liu, Y. et al. Circulating neprilysin clears brain amyloid. Mol. Cell. Neurosci. 45, 101\u2013107 (2010).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFnrn3114_CR144","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane, R. et al. RAGE mediates amyloid-\u03b2 peptide transport across the blood\u2013brain barrier and accumulation in brain. Nature Med. 9, 907\u2013913 (2003). A study showing that RAGE mediates the influx of amyloid-\u03b2 into the brain across the BBB.","journal-title":"Nature Med."},{"key":"BFnrn3114_CR145","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1172\/JCI2029","volume":"102","author":"JB Mackic","year":"1998","unstructured":"Mackic, J. B. et al. Human blood\u2013brain barrier receptors for Alzheimer's amyloid-\u03b2 1\u201340. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102, 734\u2013743 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnrn3114_CR146","doi-asserted-by":"publisher","first-page":"C1772","DOI":"10.1152\/ajpcell.2000.279.6.C1772","volume":"279","author":"R Giri","year":"2000","unstructured":"Giri, R. et al. \u03b2-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 279, C1772\u2013C1781 (2000).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"BFnrn3114_CR147","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan, S. D. et al. RAGE and amyloid-\u03b2 peptide neurotoxicity in Alzheimer's disease. Nature 382, 685\u2013691 (1996).","journal-title":"Nature"},{"key":"BFnrn3114_CR148","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","volume":"106","author":"SF Yan","year":"2010","unstructured":"Yan, S. F., Ramasamy, R. & Schmidt, A. M. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ. Res. 106, 842\u2013853 (2010).","journal-title":"Circ. Res."},{"key":"BFnrn3114_CR149","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega, K. G. et al. Decreased clearance of CNS \u03b2-amyloid in Alzheimer's disease. Science 330, 1774 (2010). An important study demonstrating faulty amyloid-\u03b2 clearance from the brain in patients with Alzheimer's disease.","journal-title":"Science"},{"key":"BFnrn3114_CR150","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","volume":"115","author":"BV Zlokovic","year":"2010","unstructured":"Zlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D. & Winkler, E. A. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid \u03b2-peptide elimination from the brain. J. Neurochem. 115, 1077\u20131089 (2010).","journal-title":"J. Neurochem."},{"key":"BFnrn3114_CR151","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane, R. et al. LRP\/amyloid \u03b2-peptide interaction mediates differential brain efflux of A\u03b2 isoforms. Neuron 43, 333\u2013344 (2004).","journal-title":"Neuron"},{"key":"BFnrn3114_CR152","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata, M. et al. Clearance of Alzheimer's amyloid-\u03b21\u201340 peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier. J. Clin. Invest. 106, 1489\u20131499 (2000). A pioneering study showing that LRP1 medaites amyloid-\u03b2 clearance from the brain to the blood across the BBB.","journal-title":"J. Clin. Invest."},{"key":"BFnrn3114_CR153","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell, R. D. et al. Transport pathways for clearance of human Alzheimer's amyloid \u03b2-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. 27, 909\u2013918 (2007).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnrn3114_CR154","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JAD-2009-1074","volume":"17","author":"LB Jaeger","year":"2009","unstructured":"Jaeger, L. B. et al. Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood\u2013brain barrier clearance, increases brain levels of amyloid-\u03b2 protein, and impairs cognition. J. Alzheimers Dis. 17, 553\u2013570 (2009).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrn3114_CR155","doi-asserted-by":"publisher","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","volume":"285","author":"M Shinohara","year":"2010","unstructured":"Shinohara, M. et al. Reduction of brain \u03b2-amyloid (A\u03b2) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and A\u03b2 clearance. J. Biol. Chem. 285, 22091\u201322102 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrn3114_CR156","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbi.2009.01.017","volume":"23","author":"LB Jaeger","year":"2009","unstructured":"Jaeger, L. B. et al. Lipopolysaccharide alters the blood\u2013brain barrier transport of amyloid \u03b2 protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav. Immun. 23, 507\u2013517 (2009).","journal-title":"Brain Behav. Immun."},{"key":"BFnrn3114_CR157","doi-asserted-by":"publisher","first-page":"34554","DOI":"10.1074\/jbc.M801487200","volume":"283","author":"K Yamada","year":"2008","unstructured":"Yamada, K. et al. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid \u03b2 peptides in an in vitro model of the blood-brain barrier cells. J. Biol. Chem. 283, 34554\u201334562 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnrn3114_CR158","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.nbd.2007.12.005","volume":"30","author":"B Nazer","year":"2008","unstructured":"Nazer, B., Hong, S. & Selkoe, D. J. LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-\u03b2 peptide in a blood\u2013brain barrier in vitro model. Neurobiol. Dis. 30, 94\u2013102 (2008).","journal-title":"Neurobiol. Dis."},{"key":"BFnrn3114_CR159","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0197-4580(01)00317-7","volume":"23","author":"OR Monro","year":"2002","unstructured":"Monro, O. R. et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-\u03b2 peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol. Aging 23, 405\u2013412 (2002).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR160","doi-asserted-by":"publisher","first-page":"20296","DOI":"10.1074\/jbc.M312946200","volume":"279","author":"J Davis","year":"2004","unstructured":"Davis, J. et al. Early-onset and robust cerebral microvascular accumulation of amyloid \u03b2-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid \u03b2-protein precursor. J. Biol. Chem. 279, 20296\u201320306 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrn3114_CR161","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane, R. et al. apoE isoform-specific disruption of amyloid \u03b2 peptide clearance from mouse brain. J. Clin. Invest. 118, 4002\u20134013 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrn3114_CR162","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos, R. B. et al. ApoE and clusterin cooperatively suppress A\u03b2 levels and deposition: evidence that ApoE regulates extracellular A\u03b2 metabolism in vivo. Neuron 41, 193\u2013202 (2004).","journal-title":"Neuron"},{"key":"BFnrn3114_CR163","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos, R. B. et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 99, 10843\u201310848 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn3114_CR164","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10611860290031831","volume":"10","author":"JR Bading","year":"2002","unstructured":"Bading, J. R. et al. Brain clearance of Alzheimer's amyloid-\u03b240 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. J. Drug Target. 10, 359\u2013368 (2002).","journal-title":"J. Drug Target."},{"key":"BFnrn3114_CR165","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"112","author":"JE Donahue","year":"2006","unstructured":"Donahue, J. E. et al. RAGE, LRP-1, and amyloid-\u03b2 protein in Alzheimer's disease. Acta Neuropathol. 112, 405\u2013415 (2006).","journal-title":"Acta Neuropathol."},{"key":"BFnrn3114_CR166","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito, J. R. et al. P-glycoprotein deficiency at the blood\u2013brain barrier increases amyloid-\u03b2 deposition in an Alzheimer disease mouse model. J. Clin. Invest. 115, 3285\u20133290 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrn3114_CR167","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.09.013","volume":"49","author":"JB Owen","year":"2010","unstructured":"Owen, J. B. et al. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for A\u03b2 accumulation in AD brain. Free Radic. Biol. Med. 49, 1798\u20131803 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrn3114_CR168","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neuro.2010.05.004","volume":"31","author":"M Behl","year":"2010","unstructured":"Behl, M. et al. Lead-induced accumulation of \u03b2-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C. Neurotoxicology 31, 524\u2013532 (2010).","journal-title":"Neurotoxicology"},{"key":"BFnrn3114_CR169","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-2010-101248","volume":"24","author":"AP Sagare","year":"2011","unstructured":"Sagare, A. P. et al. Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-\u03b2 is an early biomarker for mild cognitive impairment preceding Alzheimer's disease. J. Alzheimers Dis. 24, 25\u201334 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrn3114_CR170","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","volume":"23","author":"C Tamaki","year":"2006","unstructured":"Tamaki, C. et al. Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid \u03b2-peptide by the liver. Pharm. Res. 23, 1407\u20131416 (2006).","journal-title":"Pharm. Res."},{"key":"BFnrn3114_CR171","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1059946","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata, N. et al. Metabolic regulation of brain A\u03b2 by neprilysin. Science 292, 1550\u20131552 (2001).","journal-title":"Science"},{"key":"BFnrn3114_CR172","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","volume":"27","author":"WQ Qiu","year":"2006","unstructured":"Qiu, W. Q. & Folstein, M. F. Insulin, insulin-degrading enzyme and amyloid-\u03b2 peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 27, 190\u2013198 (2006).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn3114_CR173","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1523\/JNEUROSCI.23-26-08867.2003","volume":"23","author":"JP Melchor","year":"2003","unstructured":"Melchor, J. P., Pawlak, R. & Strickland, S. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-\u03b2 (A\u03b2) degradation and inhibits A\u03b2-induced neurodegeneration. J. Neurosci. 23, 8867\u20138871 (2003).","journal-title":"J. Neurosci."},{"key":"BFnrn3114_CR174","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1523\/JNEUROSCI.2085-06.2006","volume":"26","author":"KJ Yin","year":"2006","unstructured":"Yin, K. J. et al. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-\u03b2 peptide catabolism. J. Neurosci. 26, 10939\u201310948 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrn3114_CR175","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho, M. et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-\u03b2 peptides. Nature Med. 10, 719\u2013726 (2004).","journal-title":"Nature Med."},{"key":"BFnrn3114_CR176","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.1523\/JNEUROSCI.22-18-07873.2002","volume":"22","author":"BJ Bacskai","year":"2002","unstructured":"Bacskai, B. J. et al. Non-Fc-mediated mechanisms are involved in clearance of amyloid-\u03b2 in vivo by immunotherapy. J. Neurosci. 22, 7873\u20137878 (2002).","journal-title":"J. Neurosci."},{"key":"BFnrn3114_CR177","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman, S. E., Allison, E. K. & El Khoury, J. Microglial dysfunction and defective \u03b2-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28, 8354\u20138360 (2008).","journal-title":"J. Neurosci."},{"key":"BFnrn3114_CR178","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","volume":"18","author":"RO Weller","year":"2008","unstructured":"Weller, R. O., Subash, M., Preston, S. D., Mazanti, I. & Carare, R. O. Perivascular drainage of amyloid-\u03b2 peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. 18, 253\u2013266 (2008).","journal-title":"Brain Pathol."},{"key":"BFnrn3114_CR179","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.1161591","volume":"321","author":"DL Brody","year":"2008","unstructured":"Brody, D. L. et al. Amyloid-\u03b2 dynamics correlate with neurological status in the injured human brain. Science 321, 1221\u20131224 (2008).","journal-title":"Science"},{"key":"BFnrn3114_CR180","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth, H. W. & LaFerla, F. M. Alzheimer's disease. N.Engl. J. Med. 362, 329\u2013344 (2010).","journal-title":"N.Engl. J. Med."},{"key":"BFnrn3114_CR181","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","volume":"110","author":"J Hardy","year":"2009","unstructured":"Hardy, J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem. 110, 1129\u20131134 (2009).","journal-title":"J. Neurochem."},{"key":"BFnrn3114_CR182","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/4661052a","volume":"466","author":"C Lagier-Tourenne","year":"2010","unstructured":"Lagier-Tourenne, C. & Cleveland, D. W. Neurodegeneration: an expansion in ALS genetics. Nature 466, 1052\u20131053 (2010).","journal-title":"Nature"},{"key":"BFnrn3114_CR183","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.200908164","volume":"187","author":"H Ilieva","year":"2009","unstructured":"Ilieva, H., Polymenidou, M. & Cleveland, D. W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761\u2013772 (2009).","journal-title":"J. Cell Biol."},{"key":"BFnrn3114_CR184","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden, A. C. et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069\u20131075 (2010).","journal-title":"Nature"},{"key":"BFnrn3114_CR185","doi-asserted-by":"publisher","first-page":"12524","DOI":"10.1073\/pnas.0705044104","volume":"104","author":"A Gruzman","year":"2007","unstructured":"Gruzman, A. et al. Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 104, 12524\u201312529 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn3114_CR186","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1126\/science.1123511","volume":"312","author":"S Boillee","year":"2006","unstructured":"Boillee, S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389\u20131392 (2006). A study demonstrating that the toxicity conferred by an ALS-linked SOD1 mutant to microglia determines the lifespan of mice with an ALS-like disease.","journal-title":"Science"},{"key":"BFnrn3114_CR187","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neurosci. 11, 251\u2013253 (2008).","journal-title":"Nature Neurosci."},{"key":"BFnrn3114_CR188","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1073\/pnas.0607423103","volume":"103","author":"DR Beers","year":"2006","unstructured":"Beers, D. R. et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 103, 16021\u201316026 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn3114_CR189","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nn1885","volume":"10","author":"FP Di Giorgio","year":"2007","unstructured":"Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T. & Eggan, K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nature Neurosci. 10, 608\u2013614 (2007).","journal-title":"Nature Neurosci."},{"key":"BFnrn3114_CR190","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nn1876","volume":"10","author":"M Nagai","year":"2007","unstructured":"Nagai, M. et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nature Neurosci. 10, 615\u2013622 (2007).","journal-title":"Nature Neurosci."},{"key":"BFnrn3114_CR191","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ng1211","volume":"34","author":"D Lambrechts","year":"2003","unstructured":"Lambrechts, D. et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nature Genet. 34, 383\u2013394 (2003).","journal-title":"Nature Genet."},{"key":"BFnrn3114_CR192","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ng1742","volume":"38","author":"MJ Greenway","year":"2006","unstructured":"Greenway, M. J. et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nature Genet. 38, 411\u2013413 (2006).","journal-title":"Nature Genet."},{"key":"BFnrn3114_CR193","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/88842","volume":"28","author":"B Oosthuyse","year":"2001","unstructured":"Oosthuyse, B. et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nature Genet. 28, 131\u2013138 (2001).","journal-title":"Nature Genet."},{"key":"BFnrn3114_CR194","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P. & Kivipelto, M. Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 9, 702\u2013716 (2010).","journal-title":"Lancet Neurol."},{"key":"BFnrn3114_CR195","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tins.2011.01.005","volume":"34","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. & Griffin, J. H. Cytoprotective protein C pathways and implications for stroke and neurological disorders. Trends Neurosci. 34, 198\u2013209 (2011).","journal-title":"Trends Neurosci."},{"key":"BFnrn3114_CR196","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nn1360","volume":"8","author":"E Storkebaum","year":"2005","unstructured":"Storkebaum, E. et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature Neurosci. 8, 85\u201392 (2005).","journal-title":"Nature Neurosci."},{"key":"BFnrn3114_CR197","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature02544","volume":"429","author":"M Azzouz","year":"2004","unstructured":"Azzouz, M. et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413\u2013417 (2004).","journal-title":"Nature"},{"key":"BFnrn3114_CR198","unstructured":"US National Institutes of Health. A safety and tolerability study of intracerebroventricular administration of sNN0029 to patients with amyotrophic lateral sclerosis. ClinicalTrials.gov [online] , (2011)."},{"key":"BFnrn3114_CR199","doi-asserted-by":"publisher","first-page":"14056","DOI":"10.1523\/JNEUROSCI.3399-08.2008","volume":"28","author":"D Kieran","year":"2008","unstructured":"Kieran, D. et al. Control of motoneuron survival by angiogenin. J. Neurosci. 28, 14056\u201314061 (2008).","journal-title":"J. Neurosci."},{"key":"BFnrn3114_CR200","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1523\/JNEUROSCI.4345-06.2007","volume":"27","author":"C Lopez-Lopez","year":"2007","unstructured":"Lopez-Lopez, C., Dietrich, M. O., Metzger, F., Loetscher, H. & Torres-Aleman, I. Disturbed cross talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein\/presenilin 2 mouse model of Alzheimer's disease. J. Neurosci. 27, 824\u2013831 (2007).","journal-title":"J. Neurosci."},{"key":"BFnrn3114_CR201","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1016\/j.biomaterials.2010.03.042","volume":"31","author":"C Spuch","year":"2010","unstructured":"Spuch, C. et al. The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials 31, 5608\u20135618 (2010).","journal-title":"Biomaterials"},{"key":"BFnrn3114_CR202","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nm.2224","volume":"16","author":"M Jucker","year":"2010","unstructured":"Jucker, M. The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nature Med. 16, 1210\u20131214 (2010).","journal-title":"Nature Med."},{"key":"BFnrn3114_CR203","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/nm.2226","volume":"16","author":"EH Lo","year":"2010","unstructured":"Lo, E. H. Degeneration and repair in central nervous system disease. Nature Med. 16, 1205\u20131209 (2010).","journal-title":"Nature Med."},{"key":"BFnrn3114_CR204","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.2225","volume":"16","author":"C Van Broeckhoven","year":"2010","unstructured":"Van Broeckhoven, C. The future of genetic research on neurodegeneration. Nature Med. 16, 1215\u20131217 (2010).","journal-title":"Nature Med."},{"key":"BFnrn3114_CR205","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.arr.2010.04.002","volume":"9","author":"JC de la Torre","year":"2010","unstructured":"de la Torre, J. C. Vascular risk factor detection and control may prevent Alzheimer's disease. Ageing Res. Rev. 9, 218\u2013225 (2010).","journal-title":"Ageing Res. Rev."},{"key":"BFnrn3114_CR206","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.64.4.570","volume":"64","author":"JA Luchsinger","year":"2007","unstructured":"Luchsinger, J. A. et al. Relation of diabetes to mild cognitive impairment. Arch. Neurol. 64, 570\u2013575 (2007).","journal-title":"Arch. Neurol."},{"key":"BFnrn3114_CR207","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","volume":"7","author":"C Iadecola","year":"2008","unstructured":"Iadecola, C. & Davisson, R. L. Hypertension and cerebrovascular dysfunction. Cell Metab. 7, 476\u2013484 (2008).","journal-title":"Cell Metab."},{"key":"BFnrn3114_CR208","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","volume":"71","author":"RA Whitmer","year":"2008","unstructured":"Whitmer, R. A. et al. Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057\u20131064 (2008).","journal-title":"Neurology"},{"key":"BFnrn3114_CR209","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1096\/fj.11-0102ufm","volume":"25","author":"VT Marchesi","year":"2011","unstructured":"Marchesi, V. T. Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J. 25, 5\u201313 (2011).","journal-title":"FASEB J."},{"key":"BFnrn3114_CR210","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa022066","volume":"348","author":"SE Vermeer","year":"2003","unstructured":"Vermeer, S. E. et al. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348, 1215\u20131222 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrn3114_CR211","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","volume":"277","author":"DA Snowdon","year":"1997","unstructured":"Snowdon, D. A. et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813\u2013817 (1997).","journal-title":"JAMA"},{"key":"BFnrn3114_CR212","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nature06559","volume":"451","author":"MH Han","year":"2008","unstructured":"Han, M. H. et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451, 1076\u20131081 (2008).","journal-title":"Nature"}],"container-title":["Nature Reviews Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrn3114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrn3114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrn3114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T06:59:19Z","timestamp":1713077959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrn3114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":212,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFnrn3114"],"URL":"https:\/\/doi.org\/10.1038\/nrn3114","relation":{},"ISSN":["1471-003X","1471-0048"],"issn-type":[{"value":"1471-003X","type":"print"},{"value":"1471-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}